Skip to main content

Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer

  • 1st Edition - January 26, 2019
  • Latest edition
  • Editor: Prashant Kesharwani
  • Language: English

Nanotechnology-based Targeted Drug Delivery Systems for Lung Cancer is an indispensable resource that will help pharmaceutical scientists and clinical researchers design and devel… Read more

End of Summer Sale

Save up to 30% off

Bright savings for research, study, and discovery

Description

Nanotechnology-based Targeted Drug Delivery Systems for Lung Cancer is an indispensable resource that will help pharmaceutical scientists and clinical researchers design and develop novel drug delivery systems and devices for the treatment of lung cancer. As recent breakthroughs in nanomedicine are now making it possible to deliver drugs, genes and therapeutic agents to localized areas of disease to maximize clinical benefit, while also limiting unwanted side effects, this book explores promising approaches for the diagnosis and treatment of lung cancer using cutting-edge nanomedical technologies. Topics discussed include polymeric nanoparticles, solid lipid nanoparticles, liposomes, dendrimers, micelles and nanoemulsions.

Key features

  • Provides an overview of an array of nanotechnology-based drug delivery systems
  • Examines the design, synthesis and application of different nanocarriers in drug and gene delivery
  • Provides an in-depth understanding of the design of targeted nanotherapeutics and technologies and its implication in various site-specific cancers

Readership

Pharmaceutical scientists, clinical researchers especially cancer researchers, biomedical and biotechnology professionals, graduate students and academic researchers in pharmaceutical science and materials science working in drug delivery and nanotechnology

Table of contents

PrefacePrashant Kesharwani1. Introduction: An Overview of the anatomy and physiology of the lungShadab Md2. Major Challenges in the Lung Cancer Therapy : Distant Metastasis and Drug ResistanceChitra Thakur3. Active Targeting Systems (Ligands) / Receptor overexpressed on lung cancerBapi Gorain4. Polymeric nanoparticles based drug delivery for lung cancerLipika Ray5. Solid lipid nanoparticles based drug delivery for lung cancerAhmed Elzoghby6. Liposomes and niosomes based drug delivery for lung cancerPaulina Skupin-Mrugalska7. Dendrimers based drug delivery for lung cancerPrashant Kesharwani8. Micelles based drug delivery for lung cancerKhaled Greish9. Nanoemulsions based drug delivery for lung cancerHira Choudhury10. Nanomedicine-based inhalation treatments for lung cancerRémi Rosière11. Towards development of novel diagnostic nano-imaging platform for lung cancerZahid Hussain12. Hydrogel based drug delivery for lung cancerVijay Mishra13. Quantum dots based drug delivery for lung cancerVijay Mishra

Product details

  • Edition: 1
  • Latest edition
  • Published: January 26, 2019
  • Language: English

About the editor

PK

Prashant Kesharwani

Dr. Prashant Kesharwani is an Assistant Professor of Pharmaceutics at Dr. Harisingh Gour Vishwavidyalaya (A Central University), Sagar, India. His work focuses on translational nanomedicine, polymeric biomaterials, targeted drug delivery, nanoengineered drug delivery systems, and translational pharmaceutical research. He has contributed extensively to the scientific literature and has served as an editor of scholarly books. Dr. Kesharwani has received research funding from national agencies and has been recognized with awards and fellowships for his contributions to the field. His research interests include nanomedicine, targeted and stimuli-responsive drug delivery, polymeric nanocarriers, and related pharmaceutical applications. He is actively involved in scientific research, academic mentoring, and scholarly publishing.

Affiliations and expertise
Dr. Harisingh Gour Vishwavidyalaya University, India

View book on ScienceDirect

Read Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer on ScienceDirect